Synthesis and biological evaluation of 20(S)-substituted FL118 conjugates as novel antitumor agents
•FL118 coupled with non-steroidal anti-inflammatory drugs (NSAIDs) were synthesized.•The water-insoluble FL118-NSAIDs(6a-6d)) could not release FL118 as prodrugs.•6c could not release FL118, but showed strong inhibition of Topo1 in vitro.•The water-soluble FL118-AA (9a-9j) could release the FL118 as...
Gespeichert in:
| Veröffentlicht in: | Journal of molecular structure 2022-11, Vol.1268, p.133661, Article 133661 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | 133661 |
| container_title | Journal of molecular structure |
| container_volume | 1268 |
| creator | Lai, Jiewei Wang, Mengke Hu, Weitong Yue, Hanlin Yu, Endian Zhang, Xiangli Zhou, Yuqin Xia, Lihua Ling, Xiang Wang, Hong Li, Fengzhi Li, Qingyong |
| description | •FL118 coupled with non-steroidal anti-inflammatory drugs (NSAIDs) were synthesized.•The water-insoluble FL118-NSAIDs(6a-6d)) could not release FL118 as prodrugs.•6c could not release FL118, but showed strong inhibition of Topo1 in vitro.•The water-soluble FL118-AA (9a-9j) could release the FL118 as prodrugs.•The antitumor activity in vivo of FL118-AA were consistent with Topo I activity.
Fourteen 20(S)-substituted FL118 hybrids coupled with non-steroidal anti-inflammatory drugs (NSAIDs) or amino acids (AA) were synthesized and characterized. Most of them exhibited excellent antitumor activity against the four types of human cancer cell lines (A549, HepG2, HeLa and HCT116). FL118-NSAID derivatives(6a-6d) showed insoluble and lactone increased stability, and could not release FL118 as esterase-triggered prodrugs. FL118-AA (9a-9j) showed better water-soluble and could release the parental compound FL118 as prodrugs in both PBS and human plasma. The antitumor activity in vivo of the FL118-AA 9c, 9i and 9j were consistent with their Topo I inhibitory activity in vitro. The FL118-NSAID 6c could not release FL118, but showed strong inhibition of Topo1 in vitro and low CDOCKER energy with Topo1, the varous formulation of 6c should be try to address the insoluble problem and the drug delivery in the future.
[Display omitted] |
| doi_str_mv | 10.1016/j.molstruc.2022.133661 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11563187</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022286022013175</els_id><sourcerecordid>3128827933</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-272228d8fdb49e7884e7664c870bd83781927046ed27f042b4a87692d176a1d23</originalsourceid><addsrcrecordid>eNqFkU1vFCEYx4nR2LX6FRqO9TArbwvMSU1jbZNNPFTPhIFntmyYoQKzSb-9bLZt9OSJw_-NPD-ELihZU0Llp_16SrHUvLg1I4ytKedS0ldoRbVinSZUvEYr0pSOaUnO0LtS9oQQ2sJv0RnvN2LTxBVyd49zvYcSCrazx0NIMe2CsxHDwcbF1pBmnEbMyOXdx64sQ6mhLhU8vt5SqrFL837Z2QotX_CcDhBb0dEzpYztDuZa3qM3o40FPjy95-jX9befVzfd9sf326uv284J2teOKcaY9nr0g-hBaS1ASSmcVmTwmitNe6aIkOCZGolgg7BayZ55qqSlnvFz9PnU-7AME3jXtrON5iGHyeZHk2ww_ypzuDe7dDCUbiRvh2sNl08NOf1eoFQzheIgRjtDWorhlGnNVM95s8qT1eVUSobxZYcSc0Rk9uYZkTkiMidELXjx9y9fYs9MmuHLyQDtVocA2RQXYHbgQwZXjU_hfxt_AO6pplo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3128827933</pqid></control><display><type>article</type><title>Synthesis and biological evaluation of 20(S)-substituted FL118 conjugates as novel antitumor agents</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Lai, Jiewei ; Wang, Mengke ; Hu, Weitong ; Yue, Hanlin ; Yu, Endian ; Zhang, Xiangli ; Zhou, Yuqin ; Xia, Lihua ; Ling, Xiang ; Wang, Hong ; Li, Fengzhi ; Li, Qingyong</creator><creatorcontrib>Lai, Jiewei ; Wang, Mengke ; Hu, Weitong ; Yue, Hanlin ; Yu, Endian ; Zhang, Xiangli ; Zhou, Yuqin ; Xia, Lihua ; Ling, Xiang ; Wang, Hong ; Li, Fengzhi ; Li, Qingyong</creatorcontrib><description>•FL118 coupled with non-steroidal anti-inflammatory drugs (NSAIDs) were synthesized.•The water-insoluble FL118-NSAIDs(6a-6d)) could not release FL118 as prodrugs.•6c could not release FL118, but showed strong inhibition of Topo1 in vitro.•The water-soluble FL118-AA (9a-9j) could release the FL118 as prodrugs.•The antitumor activity in vivo of FL118-AA were consistent with Topo I activity.
Fourteen 20(S)-substituted FL118 hybrids coupled with non-steroidal anti-inflammatory drugs (NSAIDs) or amino acids (AA) were synthesized and characterized. Most of them exhibited excellent antitumor activity against the four types of human cancer cell lines (A549, HepG2, HeLa and HCT116). FL118-NSAID derivatives(6a-6d) showed insoluble and lactone increased stability, and could not release FL118 as esterase-triggered prodrugs. FL118-AA (9a-9j) showed better water-soluble and could release the parental compound FL118 as prodrugs in both PBS and human plasma. The antitumor activity in vivo of the FL118-AA 9c, 9i and 9j were consistent with their Topo I inhibitory activity in vitro. The FL118-NSAID 6c could not release FL118, but showed strong inhibition of Topo1 in vitro and low CDOCKER energy with Topo1, the varous formulation of 6c should be try to address the insoluble problem and the drug delivery in the future.
[Display omitted]</description><identifier>ISSN: 0022-2860</identifier><identifier>EISSN: 1872-8014</identifier><identifier>DOI: 10.1016/j.molstruc.2022.133661</identifier><identifier>PMID: 39545022</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Antitumor activity ; Camptothecin (CPT) ; Cancer ; FL118 ; FL118 analog ; Lactone stability ; Topoisomerase I (Topo1)</subject><ispartof>Journal of molecular structure, 2022-11, Vol.1268, p.133661, Article 133661</ispartof><rights>2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c419t-272228d8fdb49e7884e7664c870bd83781927046ed27f042b4a87692d176a1d23</cites><orcidid>0000-0002-2299-7951 ; 0000-0003-1492-3909</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022286022013175$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39545022$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lai, Jiewei</creatorcontrib><creatorcontrib>Wang, Mengke</creatorcontrib><creatorcontrib>Hu, Weitong</creatorcontrib><creatorcontrib>Yue, Hanlin</creatorcontrib><creatorcontrib>Yu, Endian</creatorcontrib><creatorcontrib>Zhang, Xiangli</creatorcontrib><creatorcontrib>Zhou, Yuqin</creatorcontrib><creatorcontrib>Xia, Lihua</creatorcontrib><creatorcontrib>Ling, Xiang</creatorcontrib><creatorcontrib>Wang, Hong</creatorcontrib><creatorcontrib>Li, Fengzhi</creatorcontrib><creatorcontrib>Li, Qingyong</creatorcontrib><title>Synthesis and biological evaluation of 20(S)-substituted FL118 conjugates as novel antitumor agents</title><title>Journal of molecular structure</title><addtitle>J Mol Struct</addtitle><description>•FL118 coupled with non-steroidal anti-inflammatory drugs (NSAIDs) were synthesized.•The water-insoluble FL118-NSAIDs(6a-6d)) could not release FL118 as prodrugs.•6c could not release FL118, but showed strong inhibition of Topo1 in vitro.•The water-soluble FL118-AA (9a-9j) could release the FL118 as prodrugs.•The antitumor activity in vivo of FL118-AA were consistent with Topo I activity.
Fourteen 20(S)-substituted FL118 hybrids coupled with non-steroidal anti-inflammatory drugs (NSAIDs) or amino acids (AA) were synthesized and characterized. Most of them exhibited excellent antitumor activity against the four types of human cancer cell lines (A549, HepG2, HeLa and HCT116). FL118-NSAID derivatives(6a-6d) showed insoluble and lactone increased stability, and could not release FL118 as esterase-triggered prodrugs. FL118-AA (9a-9j) showed better water-soluble and could release the parental compound FL118 as prodrugs in both PBS and human plasma. The antitumor activity in vivo of the FL118-AA 9c, 9i and 9j were consistent with their Topo I inhibitory activity in vitro. The FL118-NSAID 6c could not release FL118, but showed strong inhibition of Topo1 in vitro and low CDOCKER energy with Topo1, the varous formulation of 6c should be try to address the insoluble problem and the drug delivery in the future.
[Display omitted]</description><subject>Antitumor activity</subject><subject>Camptothecin (CPT)</subject><subject>Cancer</subject><subject>FL118</subject><subject>FL118 analog</subject><subject>Lactone stability</subject><subject>Topoisomerase I (Topo1)</subject><issn>0022-2860</issn><issn>1872-8014</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkU1vFCEYx4nR2LX6FRqO9TArbwvMSU1jbZNNPFTPhIFntmyYoQKzSb-9bLZt9OSJw_-NPD-ELihZU0Llp_16SrHUvLg1I4ytKedS0ldoRbVinSZUvEYr0pSOaUnO0LtS9oQQ2sJv0RnvN2LTxBVyd49zvYcSCrazx0NIMe2CsxHDwcbF1pBmnEbMyOXdx64sQ6mhLhU8vt5SqrFL837Z2QotX_CcDhBb0dEzpYztDuZa3qM3o40FPjy95-jX9befVzfd9sf326uv284J2teOKcaY9nr0g-hBaS1ASSmcVmTwmitNe6aIkOCZGolgg7BayZ55qqSlnvFz9PnU-7AME3jXtrON5iGHyeZHk2ww_ypzuDe7dDCUbiRvh2sNl08NOf1eoFQzheIgRjtDWorhlGnNVM95s8qT1eVUSobxZYcSc0Rk9uYZkTkiMidELXjx9y9fYs9MmuHLyQDtVocA2RQXYHbgQwZXjU_hfxt_AO6pplo</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Lai, Jiewei</creator><creator>Wang, Mengke</creator><creator>Hu, Weitong</creator><creator>Yue, Hanlin</creator><creator>Yu, Endian</creator><creator>Zhang, Xiangli</creator><creator>Zhou, Yuqin</creator><creator>Xia, Lihua</creator><creator>Ling, Xiang</creator><creator>Wang, Hong</creator><creator>Li, Fengzhi</creator><creator>Li, Qingyong</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2299-7951</orcidid><orcidid>https://orcid.org/0000-0003-1492-3909</orcidid></search><sort><creationdate>20221115</creationdate><title>Synthesis and biological evaluation of 20(S)-substituted FL118 conjugates as novel antitumor agents</title><author>Lai, Jiewei ; Wang, Mengke ; Hu, Weitong ; Yue, Hanlin ; Yu, Endian ; Zhang, Xiangli ; Zhou, Yuqin ; Xia, Lihua ; Ling, Xiang ; Wang, Hong ; Li, Fengzhi ; Li, Qingyong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-272228d8fdb49e7884e7664c870bd83781927046ed27f042b4a87692d176a1d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antitumor activity</topic><topic>Camptothecin (CPT)</topic><topic>Cancer</topic><topic>FL118</topic><topic>FL118 analog</topic><topic>Lactone stability</topic><topic>Topoisomerase I (Topo1)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lai, Jiewei</creatorcontrib><creatorcontrib>Wang, Mengke</creatorcontrib><creatorcontrib>Hu, Weitong</creatorcontrib><creatorcontrib>Yue, Hanlin</creatorcontrib><creatorcontrib>Yu, Endian</creatorcontrib><creatorcontrib>Zhang, Xiangli</creatorcontrib><creatorcontrib>Zhou, Yuqin</creatorcontrib><creatorcontrib>Xia, Lihua</creatorcontrib><creatorcontrib>Ling, Xiang</creatorcontrib><creatorcontrib>Wang, Hong</creatorcontrib><creatorcontrib>Li, Fengzhi</creatorcontrib><creatorcontrib>Li, Qingyong</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of molecular structure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lai, Jiewei</au><au>Wang, Mengke</au><au>Hu, Weitong</au><au>Yue, Hanlin</au><au>Yu, Endian</au><au>Zhang, Xiangli</au><au>Zhou, Yuqin</au><au>Xia, Lihua</au><au>Ling, Xiang</au><au>Wang, Hong</au><au>Li, Fengzhi</au><au>Li, Qingyong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and biological evaluation of 20(S)-substituted FL118 conjugates as novel antitumor agents</atitle><jtitle>Journal of molecular structure</jtitle><addtitle>J Mol Struct</addtitle><date>2022-11-15</date><risdate>2022</risdate><volume>1268</volume><spage>133661</spage><pages>133661-</pages><artnum>133661</artnum><issn>0022-2860</issn><eissn>1872-8014</eissn><abstract>•FL118 coupled with non-steroidal anti-inflammatory drugs (NSAIDs) were synthesized.•The water-insoluble FL118-NSAIDs(6a-6d)) could not release FL118 as prodrugs.•6c could not release FL118, but showed strong inhibition of Topo1 in vitro.•The water-soluble FL118-AA (9a-9j) could release the FL118 as prodrugs.•The antitumor activity in vivo of FL118-AA were consistent with Topo I activity.
Fourteen 20(S)-substituted FL118 hybrids coupled with non-steroidal anti-inflammatory drugs (NSAIDs) or amino acids (AA) were synthesized and characterized. Most of them exhibited excellent antitumor activity against the four types of human cancer cell lines (A549, HepG2, HeLa and HCT116). FL118-NSAID derivatives(6a-6d) showed insoluble and lactone increased stability, and could not release FL118 as esterase-triggered prodrugs. FL118-AA (9a-9j) showed better water-soluble and could release the parental compound FL118 as prodrugs in both PBS and human plasma. The antitumor activity in vivo of the FL118-AA 9c, 9i and 9j were consistent with their Topo I inhibitory activity in vitro. The FL118-NSAID 6c could not release FL118, but showed strong inhibition of Topo1 in vitro and low CDOCKER energy with Topo1, the varous formulation of 6c should be try to address the insoluble problem and the drug delivery in the future.
[Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>39545022</pmid><doi>10.1016/j.molstruc.2022.133661</doi><orcidid>https://orcid.org/0000-0002-2299-7951</orcidid><orcidid>https://orcid.org/0000-0003-1492-3909</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-2860 |
| ispartof | Journal of molecular structure, 2022-11, Vol.1268, p.133661, Article 133661 |
| issn | 0022-2860 1872-8014 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11563187 |
| source | Elsevier ScienceDirect Journals Complete |
| subjects | Antitumor activity Camptothecin (CPT) Cancer FL118 FL118 analog Lactone stability Topoisomerase I (Topo1) |
| title | Synthesis and biological evaluation of 20(S)-substituted FL118 conjugates as novel antitumor agents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T20%3A44%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20biological%20evaluation%20of%2020(S)-substituted%20FL118%20conjugates%20as%20novel%20antitumor%20agents&rft.jtitle=Journal%20of%20molecular%20structure&rft.au=Lai,%20Jiewei&rft.date=2022-11-15&rft.volume=1268&rft.spage=133661&rft.pages=133661-&rft.artnum=133661&rft.issn=0022-2860&rft.eissn=1872-8014&rft_id=info:doi/10.1016/j.molstruc.2022.133661&rft_dat=%3Cproquest_pubme%3E3128827933%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3128827933&rft_id=info:pmid/39545022&rft_els_id=S0022286022013175&rfr_iscdi=true |